<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NVCR
Novocure
$
()


  • FDA accepts Novocure PMA application for TTFields therapy in NSCLC

    1/18/2024 - 07:09am
  • Novocure enrolls final patient in TRIDENT clinical trial

    1/9/2024 - 07:15am
  • Fly Intel: Pre-market Movers

    1/8/2024 - 09:05am
  • Novocure sees FY23 revenue $509.3M, consensus $505.05M

    1/8/2024 - 07:22am
  • Novocure reports preliminary Q4 revenue $133.8M, consensus $129.3M

    1/8/2024 - 07:19am
  • Novocure reports preliminary Q4 revenue $133.8M, consensus $129.3M

    1/8/2024 - 07:19am
  • Novocure names Nicolas Leupin CMO

    1/4/2024 - 16:05pm
  • Novocure to reduce workforce by 13% in strategic restructuring

    11/28/2023 - 07:38am
  • Boeing upgraded, Arm initiated: Wall Street's top analyst calls

    11/20/2023 - 09:56am
  • Novocure reinstated with Neutral from Underweight at JPMorgan

    11/20/2023 - 05:45am
  • Novocure reports Q3 EPS (46c), consensus (52c)

    10/26/2023 - 07:31am
  • Novocure teams with Stanford to create TTFields research program

    10/12/2023 - 08:06am
  • Novocure announces data from the randomized phase 3 LUNAR clinical trial

    8/29/2023 - 18:34pm
  • Novocure price target lowered to $49 from $102 at Wells Fargo

    8/29/2023 - 06:06am
  • What You Missed On Wall Street On Monday

    8/28/2023 - 16:24pm
dynamic_feed Breaking News